CoChat

Impact of Infectious Diseases Consultation on Mortality of Cryptococcal Infection in Patients Without HIV

Open access
Spec, Andrej, Olsen, Margaret A., Raval, Krunal, Powderly, William G. · 2017 · Clinical Infectious Diseases
Cited by 53

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background.: An infectious disease (ID) consultation (consult) is often obtained to treat patients with cryptococcosis due to the complex nature of the disease, but has never been demonstrated to impact outcomes. Methods.: We assembled a retrospective cohort of 147 consecutive cases of cryptococcosis in patients without human immunodeficiency virus. Patients who were diagnosed <24 hours prior to death were excluded. Survival analysis was performed with Cox regression with survival censored past 90 days. Results.: The patients with an ID consult had a higher fungal burden but a lower 90-day mortality compared with patients without ID involvement (27% vs 45%; P < .001), with an adjusted hazard ratio of not receiving an ID consult of 4.2 (95% confidence interval, 2.2–7.6). The ID consult group was more likely to receive an indicated lumbar puncture (86% vs 32%; P < .001), and more likely to be treated with amphotericin B (AmB) (87% vs 24%; P < .001) and flucytosine (5-FC) (57% vs 16%; P < .001) when indicated. The duration of therapy with AmB (14 vs 11 days; P = .05) and 5-FC (7.5 days vs 1 day; P < .001) was longer in the ID consult group. Conclusions.: Patients who received an ID consult were significantly less likely to die in the 90 days following diagnosis. Patients seen by ID physicians were more likely to be managed according to evidence-based practice established by randomized controlled trials and published in Infectious Diseases Society of America guidelines. These data suggest that an ID consult should be an integral part of clinical care of patients with cryptococcosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciw786

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Spec, A., Olsen, M. A., Raval, K., & Powderly, W. G.
Venue
Clinical Infectious Diseases
Published
2017-02-09
Volume
64
Issue
5
Pages
558-564
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2560337566
Cited by
53
References
3
FWCI
7.09
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.